Published 2022
| Version v1
Publication
How do we optimize the prescribing of intravenous polymyxins to increase their longevity and efficacy in critically ill patients?
Additional details
- URL
- https://hdl.handle.net/11567/1220383
- URN
- urn:oai:iris.unige.it:11567/1220383
- Origin repository
- UNIGE